• Issue

    Clinical and Translational Medicine: Volume 15, Issue 6

    June 2025

ISSUE INFORMATION

Open Access

CLINICAL AND TRANSLATIONAL MEDICINE

  • First Published: 09 June 2025

RESEARCH ARTICLE

Open Access

Elevation of ISG15 promotes diabetic kidney disease by modulating renal tubular epithelial cell pyroptosis

  • First Published: 03 June 2025
Elevation of ISG15 promotes diabetic kidney disease by modulating renal tubular epithelial cell pyroptosis

  1. ISG15 is highly expressed in both DKD mice and renal tubular epithelial cell cultured in HG condition.

  2. ISG15 promotes DKD pyroptosis via NLRP3–CASP1–GSDMD axis.

  3. ISG15–mtDNA–STING emerges as a critical hub that integrates the processes of pyroptosis

.

Open Access

Fibroblasts-specific p16INK4a exacerbates inflammageing-mediated post-infarction ventricular remodelling through interacting with STAT3 to regulate NLRP3 transcription

  • First Published: 03 June 2025
Fibroblasts-specific p16INK4a exacerbates inflammageing-mediated post-infarction ventricular remodelling through interacting with STAT3 to regulate NLRP3 transcription

  • In ageing fibroblasts, p16INK4a concurrently enhanced STAT3 di-methylation mediated by EZH2 and suppressed the assembly of Bmi-1-EZH2/BCL-6 complexes at the NLRP3 promoter region.
  • These dual regulatory actions synergistically upregulated STAT3-dependent NLRP3 transcription, thereby exacerbating inflammageing-driven ventricular remodelling following myocardial infarction.
  • FNLM-nanocaged p16INK4a-siRNA prevents post-infarction ventricular remodelling through inhibiting NLRP3 transcription in targeted cardiac fibroblasts.

RESEARCH ARTICLE

Open Access

Targeting the MDK/c-Myc complex to overcome temozolomide resistance in glioma

  • First Published: 04 June 2025
Targeting the MDK/c-Myc complex to overcome temozolomide resistance in glioma

ACT001 disrupts the MDK/c-Myc complex, enhancing c-Myc ubiquitination and overcoming temozolomide resistance in glioma. Combining ACT001 with temozolomide synergistically inhibits tumour growth and progression, offering a promising therapeutic strategy for glioma patients, particularly those with high MDK expression.

Open Access

DDR2-mediated autophagy inhibition contributes to angiotensin II-induced adventitial remodeling

  • First Published: 04 June 2025
DDR2-mediated autophagy inhibition contributes to angiotensin II-induced adventitial remodeling

Ddr2 promotes PI3K/Akt/mTOR mediated autophagy inhibition, which contributes to Ang II-induced AF phenotypic switch.

Open Access

LncRNA MIR503HG regulates NETs-mediated NLRP3 inflammasome activation and NSCLC metastasis by enhancing the ubiquitination of C/EBPβ

  • First Published: 09 June 2025
LncRNA MIR503HG regulates NETs-mediated NLRP3 inflammasome activation and NSCLC metastasis by enhancing the ubiquitination of C/EBPβ

  1. NETs suppress the expression of MIR503HG by inducing promoter DNA methylation.
  2. C/EBPβ binds to the NLRP3 promoter to promote NLRP3 expression.
  3. MIR503HG inhibits the expression of C/EBPβ protein by promoting the interaction between C/EBPβ and the E3 ubiquitin ligase RNF43, thereby repressing NLRP3 expression.

REVIEW

Open Access

Antisenescence therapies for age-related bone loss: Target factors, medicines, biomedical materials

  • First Published: 09 June 2025
Antisenescence therapies for age-related bone loss: Target factors, medicines, biomedical materials

With extended lifespans causing population aging, bone aging has become a worldwide issue. Cellular senescence in the bone microenvironment causes bone degeneration and dysfunction. This review summarises targets in cellular senescence and bone aging while detailing potential therapeutic strategies, including novel medicines and innovative biomedical materials. https://BioRender.com/0wqyt7g

RESEARCH ARTICLE

Open Access

MLKL‒OPTN axis regulates herpesvirus-induced neurological sequelae

  • First Published: 09 June 2025
MLKL‒OPTN axis regulates herpesvirus-induced neurological sequelae

  1. MLKL plays a significant role in regulating endosomal transport of HSV-1 to nucleus during early stages of infection.
  2. Formation of p-MLKL bodies during HSV-1 infection leads to death of oligodendrocyte and subsequent demyelination.
  3. OPTN can negatively modulate MLKL levels to restrict infection and consequential oligodendrocyte death during HSV-1 infection.

REVIEW

Open Access

Neutrophil extracellular traps in cancer: From mechanisms to treatments

  • First Published: 13 June 2025
Neutrophil extracellular traps in cancer: From mechanisms to treatments

Neutrophil extracellular traps are intricately linked to the tumor microenvironment and play a crucial role in tumorigenesis, metastasis, and related complications. Consequently, NETs-based tumor biomarkers and therapeutic strategies warrant significant attention.

RESEARCH ARTICLE

RESEARCH ARTICLE

Open Access

Hypoxia-induced PGK1 expression promotes esophageal squamous cell carcinoma progression via stimulating MYH9-mediated GSK3β/β-catenin signalling

  • First Published: 18 June 2025
Hypoxia-induced PGK1 expression promotes esophageal squamous cell carcinoma progression via stimulating MYH9-mediated GSK3β/β-catenin signalling

Under hypoxic conditions, elevated PGK1 interacts with MYH9, promoting the ubiquitination and degradation of GSK3β, which leads to β-catenin stabilisation and nuclear translocation. Activated β-catenin increases the transcription of c-Myc and downstream targets genes enhancing cancer stemness, epithelial-to-mesenchymal transition (EMT), metastasis, and ESCC recurrence.

RESEARCH ARTICLE

Open Access

Engineered small extracellular vesicles for targeted delivery of perlecan to stabilise the blood–spinal cord barrier after spinal cord injury

  • First Published: 19 June 2025
Engineered small extracellular vesicles for targeted delivery of perlecan to stabilise the blood–spinal cord barrier after spinal cord injury

  • Perlecan, a crucial component of basement membranes that plays a vital role in stabilising BSCB homeostasis and functions, was found to be upregulated in M2-sEVs.
  • M2-sEVs decorated with RGD peptide can effectively target the neovascular endothelium surfaces at the injured spinal cord site.
  • RGD-M2-sEVs promote BSCB restoration by transporting perlecan to neovascular endothelial cells, representing a potential strategy for SCI treatment.

RESEARCH ARTICLE

Open Access

OXA1L deficiency causes mitochondrial myopathy via reactive oxygen species regulated nuclear factor kappa B signalling pathway

  • First Published: 23 June 2025
OXA1L deficiency causes mitochondrial myopathy via reactive oxygen species regulated nuclear factor kappa B signalling pathway

  1. OXA1L gene bi-allelic variants cause mitochondrial myopathy.
  2. OXA1L deficiency results in combined mitochondrial respiratory chain defects and OXPHOS impairments.
  3. OXA1L deficiency leads to elevated ROS production, which may activate the NF-κB signalling pathway, disturbing myogenic gene expression and triggering cell apoptosis.